Skip to content

Alto Ingredients, Inc. ALTO Granted (in shares)

Granted (in shares) at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
1.3M-16.9%
Norwood Financial logo
Norwood FinancialNWFL
$23.9K-1.1%
DJT
Trump Media & Technology GroupDJT
0-100%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
13.5K
Southern First Bancshares logo
Southern First BancsharesSFST
65.7K+0.5%
CNB Financial logo
CNB FinancialCCNE
0

Other financials

Income statement

See full
Revenue$224.7M-0.8%
Gross profit$9.2M+610%
Operating income$2.5M+128%
Net income$4.3M+137%
EPS (diluted)$0.05+131%

Balance sheet

See full
Cash & equivalents$21.6M-20.3%
Total debt$91.3M-30.5%
Total equity$249.9M+16.8%
Total assets$386.3M-4.0%

Cash flow

See full
Operating cash flow$4.2M+123%
CapEx$909.0K+70.9%
Free cash flow$3.3M+118%

Valuation

See full
Market cap$385.88M+342%
Enterprise value$455.51M+138%
P/E13.2×
P/S0.4×+0.3×

Profitability

See full
Gross margin5%
Operating margin2.1%+1.2pp
Net margin3.2%+1.9pp
FCF margin3.4%

Returns & leverage

See full
Return on equity12.6%+7.6pp
Debt / equity0.4×-0.2×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Alto Ingredients, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.

The official record: Alto Ingredients, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Ingredients, Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Ingredients, Inc.'s granted (in shares)?
Alto Ingredients, Inc. (ALTO) reported granted (in shares) of 1.3M in Q4 2025.
What does granted (in shares) mean?
The total number of equity-based instruments, such as restricted stock units or performance shares, granted to employees and directors during the period. This metric provides insight into the company's long-term incentive strategy and potential future shareholder dilution.